New Developments in Chemical Engineering for the Production of Drug Substances
The pharmaceutical industry is moving towards a profitability gap between increasing costs and decreasing prices. Finally, management has understood that mergers and acquisitions, high throughput screening, and biotechnology alone will not save the companies' earnings. Therefore, classical appr...
Gespeichert in:
| Veröffentlicht in: | Engineering in life sciences 2004-01, Vol.4 (1), p.15-24 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 24 |
|---|---|
| container_issue | 1 |
| container_start_page | 15 |
| container_title | Engineering in life sciences |
| container_volume | 4 |
| creator | Behr, A. Brehme, V.A. Ewers, Ch.L.J. Grön, H. Kimmel, T. Küppers, S. Symietz, I. |
| description | The pharmaceutical industry is moving towards a profitability gap between increasing costs and decreasing prices. Finally, management has understood that mergers and acquisitions, high throughput screening, and biotechnology alone will not save the companies' earnings. Therefore, classical approaches like the optimization of production technologies for drug substances, that might help to increase profitability, are receiving increasing attention. This paper shows how the combination of innovative components will guide the way to very efficient and cost‐effective production. The first component is the design and manufacturing of production facilities. The second component is a process streamlining of the production process. The key technologies discussed here are process control and miniplant technology. For these technologies a brief outlook on future trends is given.
The pharmaceutical industry is moving towards a profitability gap between increasing costs and decreasing prices. Classical approaches like the optimization of production technologies for drug substances, that might help to increase profitability, are receiving increasing attention. This paper shows how the combination of innovative components will guide the way to very efficient and cost‐effective production. |
| doi_str_mv | 10.1002/elsc.200406127 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17700503</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17700503</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5297-dd7bc658345fc55d9dd5a12abba78043db5d1bb643a6410aa1522851180111df3</originalsourceid><addsrcrecordid>eNqFkDFv2zAQRoWgAeKmXTtzSTa5d6QoymNhO0kBwynqFCm6EBR5spnKkkNKSfPva8OGky3T3fC9d7gvSb4gDBGAf6U62iEHyCBHrk6SAeZYpLzIxYfDDjyDs-RjjA8AqIoCB8l8Ts9sQk9Ut5s1NV1kvmHjFa29NTWbNkvfEAXfLFnVBtatiP0Irett59uGtRWbhH7JFn0ZO9NYip-S08rUkT4f5nny62p6N75JZ7fX38ffZqmVfKRS51Rpc1mITFZWSjdyThrkpiyNKiATrpQOyzLPhMkzBGNQcl5IxAIQ0VXiPLncezehfewpdnrto6W6Ng21fdSoFIAEsQ0O90Eb2hgDVXoT_NqEF42gd7XpXW36WNsWuDiYTdxWUIXtXz6-UjJTOYqdeLTPPfuaXt6x6ulsMX57I92zPnb078ia8FfnSiip7-fXWonF_c_ff-60EP8B1KGNQw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17700503</pqid></control><display><type>article</type><title>New Developments in Chemical Engineering for the Production of Drug Substances</title><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Behr, A. ; Brehme, V.A. ; Ewers, Ch.L.J. ; Grön, H. ; Kimmel, T. ; Küppers, S. ; Symietz, I.</creator><creatorcontrib>Behr, A. ; Brehme, V.A. ; Ewers, Ch.L.J. ; Grön, H. ; Kimmel, T. ; Küppers, S. ; Symietz, I.</creatorcontrib><description>The pharmaceutical industry is moving towards a profitability gap between increasing costs and decreasing prices. Finally, management has understood that mergers and acquisitions, high throughput screening, and biotechnology alone will not save the companies' earnings. Therefore, classical approaches like the optimization of production technologies for drug substances, that might help to increase profitability, are receiving increasing attention. This paper shows how the combination of innovative components will guide the way to very efficient and cost‐effective production. The first component is the design and manufacturing of production facilities. The second component is a process streamlining of the production process. The key technologies discussed here are process control and miniplant technology. For these technologies a brief outlook on future trends is given.
The pharmaceutical industry is moving towards a profitability gap between increasing costs and decreasing prices. Classical approaches like the optimization of production technologies for drug substances, that might help to increase profitability, are receiving increasing attention. This paper shows how the combination of innovative components will guide the way to very efficient and cost‐effective production.</description><identifier>ISSN: 1618-0240</identifier><identifier>EISSN: 1618-2863</identifier><identifier>DOI: 10.1002/elsc.200406127</identifier><language>eng</language><publisher>Weinheim: WILEY-VCH Verlag</publisher><subject>Biological and medical sciences ; Biotechnology ; Chemical engineering ; Fundamental and applied biological sciences. Psychology ; Miniplants ; Plant optimization ; Process control</subject><ispartof>Engineering in life sciences, 2004-01, Vol.4 (1), p.15-24</ispartof><rights>Copyright © 2004 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5297-dd7bc658345fc55d9dd5a12abba78043db5d1bb643a6410aa1522851180111df3</citedby><cites>FETCH-LOGICAL-c5297-dd7bc658345fc55d9dd5a12abba78043db5d1bb643a6410aa1522851180111df3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Felsc.200406127$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15476133$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Behr, A.</creatorcontrib><creatorcontrib>Brehme, V.A.</creatorcontrib><creatorcontrib>Ewers, Ch.L.J.</creatorcontrib><creatorcontrib>Grön, H.</creatorcontrib><creatorcontrib>Kimmel, T.</creatorcontrib><creatorcontrib>Küppers, S.</creatorcontrib><creatorcontrib>Symietz, I.</creatorcontrib><title>New Developments in Chemical Engineering for the Production of Drug Substances</title><title>Engineering in life sciences</title><addtitle>Eng. Life Sci</addtitle><description>The pharmaceutical industry is moving towards a profitability gap between increasing costs and decreasing prices. Finally, management has understood that mergers and acquisitions, high throughput screening, and biotechnology alone will not save the companies' earnings. Therefore, classical approaches like the optimization of production technologies for drug substances, that might help to increase profitability, are receiving increasing attention. This paper shows how the combination of innovative components will guide the way to very efficient and cost‐effective production. The first component is the design and manufacturing of production facilities. The second component is a process streamlining of the production process. The key technologies discussed here are process control and miniplant technology. For these technologies a brief outlook on future trends is given.
The pharmaceutical industry is moving towards a profitability gap between increasing costs and decreasing prices. Classical approaches like the optimization of production technologies for drug substances, that might help to increase profitability, are receiving increasing attention. This paper shows how the combination of innovative components will guide the way to very efficient and cost‐effective production.</description><subject>Biological and medical sciences</subject><subject>Biotechnology</subject><subject>Chemical engineering</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Miniplants</subject><subject>Plant optimization</subject><subject>Process control</subject><issn>1618-0240</issn><issn>1618-2863</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNqFkDFv2zAQRoWgAeKmXTtzSTa5d6QoymNhO0kBwynqFCm6EBR5spnKkkNKSfPva8OGky3T3fC9d7gvSb4gDBGAf6U62iEHyCBHrk6SAeZYpLzIxYfDDjyDs-RjjA8AqIoCB8l8Ts9sQk9Ut5s1NV1kvmHjFa29NTWbNkvfEAXfLFnVBtatiP0Irett59uGtRWbhH7JFn0ZO9NYip-S08rUkT4f5nny62p6N75JZ7fX38ffZqmVfKRS51Rpc1mITFZWSjdyThrkpiyNKiATrpQOyzLPhMkzBGNQcl5IxAIQ0VXiPLncezehfewpdnrto6W6Ng21fdSoFIAEsQ0O90Eb2hgDVXoT_NqEF42gd7XpXW36WNsWuDiYTdxWUIXtXz6-UjJTOYqdeLTPPfuaXt6x6ulsMX57I92zPnb078ia8FfnSiip7-fXWonF_c_ff-60EP8B1KGNQw</recordid><startdate>20040101</startdate><enddate>20040101</enddate><creator>Behr, A.</creator><creator>Brehme, V.A.</creator><creator>Ewers, Ch.L.J.</creator><creator>Grön, H.</creator><creator>Kimmel, T.</creator><creator>Küppers, S.</creator><creator>Symietz, I.</creator><general>WILEY-VCH Verlag</general><general>WILEY‐VCH Verlag</general><general>Wiley-VCH</general><scope>BSCLL</scope><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20040101</creationdate><title>New Developments in Chemical Engineering for the Production of Drug Substances</title><author>Behr, A. ; Brehme, V.A. ; Ewers, Ch.L.J. ; Grön, H. ; Kimmel, T. ; Küppers, S. ; Symietz, I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5297-dd7bc658345fc55d9dd5a12abba78043db5d1bb643a6410aa1522851180111df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Biological and medical sciences</topic><topic>Biotechnology</topic><topic>Chemical engineering</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Miniplants</topic><topic>Plant optimization</topic><topic>Process control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Behr, A.</creatorcontrib><creatorcontrib>Brehme, V.A.</creatorcontrib><creatorcontrib>Ewers, Ch.L.J.</creatorcontrib><creatorcontrib>Grön, H.</creatorcontrib><creatorcontrib>Kimmel, T.</creatorcontrib><creatorcontrib>Küppers, S.</creatorcontrib><creatorcontrib>Symietz, I.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Engineering in life sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Behr, A.</au><au>Brehme, V.A.</au><au>Ewers, Ch.L.J.</au><au>Grön, H.</au><au>Kimmel, T.</au><au>Küppers, S.</au><au>Symietz, I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>New Developments in Chemical Engineering for the Production of Drug Substances</atitle><jtitle>Engineering in life sciences</jtitle><addtitle>Eng. Life Sci</addtitle><date>2004-01-01</date><risdate>2004</risdate><volume>4</volume><issue>1</issue><spage>15</spage><epage>24</epage><pages>15-24</pages><issn>1618-0240</issn><eissn>1618-2863</eissn><abstract>The pharmaceutical industry is moving towards a profitability gap between increasing costs and decreasing prices. Finally, management has understood that mergers and acquisitions, high throughput screening, and biotechnology alone will not save the companies' earnings. Therefore, classical approaches like the optimization of production technologies for drug substances, that might help to increase profitability, are receiving increasing attention. This paper shows how the combination of innovative components will guide the way to very efficient and cost‐effective production. The first component is the design and manufacturing of production facilities. The second component is a process streamlining of the production process. The key technologies discussed here are process control and miniplant technology. For these technologies a brief outlook on future trends is given.
The pharmaceutical industry is moving towards a profitability gap between increasing costs and decreasing prices. Classical approaches like the optimization of production technologies for drug substances, that might help to increase profitability, are receiving increasing attention. This paper shows how the combination of innovative components will guide the way to very efficient and cost‐effective production.</abstract><cop>Weinheim</cop><pub>WILEY-VCH Verlag</pub><doi>10.1002/elsc.200406127</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1618-0240 |
| ispartof | Engineering in life sciences, 2004-01, Vol.4 (1), p.15-24 |
| issn | 1618-0240 1618-2863 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_17700503 |
| source | Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals |
| subjects | Biological and medical sciences Biotechnology Chemical engineering Fundamental and applied biological sciences. Psychology Miniplants Plant optimization Process control |
| title | New Developments in Chemical Engineering for the Production of Drug Substances |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T20%3A37%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=New%20Developments%20in%20Chemical%20Engineering%20for%20the%20Production%20of%20Drug%20Substances&rft.jtitle=Engineering%20in%20life%20sciences&rft.au=Behr,%20A.&rft.date=2004-01-01&rft.volume=4&rft.issue=1&rft.spage=15&rft.epage=24&rft.pages=15-24&rft.issn=1618-0240&rft.eissn=1618-2863&rft_id=info:doi/10.1002/elsc.200406127&rft_dat=%3Cproquest_cross%3E17700503%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17700503&rft_id=info:pmid/&rfr_iscdi=true |